Cilofexor, another non-steroidal FXR agonist, decreased serum ALP, γGT, AST, ALT, and bile acid levels in PSC [109] and PBC patients, according to preliminary data [110]. This evidence concerns the gene NR1H4 and primary biliary cholangitis.